Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.06
CNC's Cash-to-Debt is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CNC: 1.06 )
Ranked among companies with meaningful Cash-to-Debt only.
CNC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.42  Med: 1.63 Max: No Debt
Current: 1.06
Equity-to-Asset 0.29
CNC's Equity-to-Asset is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. CNC: 0.29 )
Ranked among companies with meaningful Equity-to-Asset only.
CNC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27  Med: 0.38 Max: 0.64
Current: 0.29
0.27
0.64
Debt-to-Equity 0.74
CNC's Debt-to-Equity is ranked lower than
61% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.66 vs. CNC: 0.74 )
Ranked among companies with meaningful Debt-to-Equity only.
CNC' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.45  Med: 0.5 Max: 1.26
Current: 0.74
-0.45
1.26
Interest Coverage 6.02
CNC's Interest Coverage is ranked lower than
83% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. CNC: 6.02 )
Ranked among companies with meaningful Interest Coverage only.
CNC' s Interest Coverage Range Over the Past 10 Years
Min: 3.54  Med: 8.6 Max: 16.4
Current: 6.02
3.54
16.4
Piotroski F-Score: 6
Altman Z-Score: 3.19
Beneish M-Score: -2.83
WACC vs ROIC
7.10%
13.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 3.32
CNC's Operating Margin % is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. CNC: 3.32 )
Ranked among companies with meaningful Operating Margin % only.
CNC' s Operating Margin % Range Over the Past 10 Years
Min: 1.33  Med: 3.1 Max: 3.91
Current: 3.32
1.33
3.91
Net Margin % 1.73
CNC's Net Margin % is ranked lower than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. CNC: 1.73 )
Ranked among companies with meaningful Net Margin % only.
CNC' s Net Margin % Range Over the Past 10 Years
Min: 0.02  Med: 1.84 Max: 2.65
Current: 1.73
0.02
2.65
ROE % 13.57
CNC's ROE % is ranked lower than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. CNC: 13.57 )
Ranked among companies with meaningful ROE % only.
CNC' s ROE % Range Over the Past 10 Years
Min: 0.21  Med: 15.14 Max: 19.8
Current: 13.57
0.21
19.8
ROA % 3.92
CNC's ROA % is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. CNC: 3.92 )
Ranked among companies with meaningful ROA % only.
CNC' s ROA % Range Over the Past 10 Years
Min: 0.08  Med: 5.35 Max: 7.28
Current: 3.92
0.08
7.28
ROC (Joel Greenblatt) % 217.12
CNC's ROC (Joel Greenblatt) % is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 89.82 vs. CNC: 217.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CNC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 39.42  Med: 76.26 Max: 217.12
Current: 217.12
39.42
217.12
3-Year Revenue Growth Rate 36.90
CNC's 3-Year Revenue Growth Rate is ranked higher than
95% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CNC: 36.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CNC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 26.35 Max: 40.5
Current: 36.9
0
40.5
3-Year EBITDA Growth Rate 46.20
CNC's 3-Year EBITDA Growth Rate is ranked higher than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. CNC: 46.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CNC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 22.6 Max: 171.9
Current: 46.2
0
171.9
3-Year EPS without NRI Growth Rate 33.60
CNC's 3-Year EPS without NRI Growth Rate is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. CNC: 33.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CNC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 19.3 Max: 51.6
Current: 33.6
0
51.6
» CNC's 30-Y Financials

Financials (Next Earnings Date: 2017-10-24)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

CNC Guru Trades in Q3 2016

John Hussman 100,000 sh (New)
Joel Greenblatt 14,239 sh (+178.38%)
Andreas Halvorsen 816,672 sh (+66.91%)
George Soros Sold Out
Steven Cohen Sold Out
Jim Simons Sold Out
Columbia Wanger 702,187 sh (-20.96%)
» More
Q4 2016

CNC Guru Trades in Q4 2016

Lee Ainslie 1,399,062 sh (New)
David Tepper 785,000 sh (New)
Jim Simons 456,716 sh (New)
Steven Cohen 290,300 sh (New)
Pioneer Investments 83,785 sh (New)
Paul Tudor Jones 14,393 sh (New)
Richard Snow 384,091 sh (New)
Andreas Halvorsen 1,653,652 sh (+102.49%)
Joel Greenblatt 22,449 sh (+57.66%)
Columbia Wanger 766,756 sh (+9.20%)
John Hussman Sold Out
» More
Q1 2017

CNC Guru Trades in Q1 2017

Vanguard Health Care Fund 668,300 sh (New)
Pioneer Investments 1,369,670 sh (+1534.74%)
Richard Snow 840,445 sh (+118.81%)
Jim Simons 812,616 sh (+77.93%)
Paul Tudor Jones 24,538 sh (+70.49%)
David Tepper 1,174,597 sh (+49.63%)
Andreas Halvorsen 2,280,256 sh (+37.89%)
Joel Greenblatt 25,335 sh (+12.86%)
Lee Ainslie Sold Out
Columbia Wanger 558,022 sh (-27.22%)
Steven Cohen 100,000 sh (-65.55%)
» More
Q2 2017

CNC Guru Trades in Q2 2017

Ken Heebner 280,000 sh (New)
John Hussman 50,000 sh (New)
Eaton Vance Worldwide Health Sciences Fund 128,662 sh (New)
Paul Tudor Jones 32,175 sh (+31.12%)
Pioneer Investments 1,728,324 sh (+26.19%)
Jim Simons 886,316 sh (+9.07%)
Joel Greenblatt 26,192 sh (+3.38%)
Vanguard Health Care Fund 668,300 sh (unchged)
Columbia Wanger Sold Out
Andreas Halvorsen Sold Out
Steven Cohen Sold Out
Richard Snow 809,748 sh (-3.65%)
David Tepper 964,397 sh (-17.90%)
» More
» Details

Insider Trades

Latest Guru Trades with CNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Tepper 2017-06-30 Reduce -17.90%0.25%$69.77 - $84.15 $ 93.0123%964,397
Ken Heebner 2017-06-30 New Buy1.02%$69.77 - $84.15 $ 93.0123%280,000
Joel Greenblatt 2017-06-30 Add 3.38%$69.77 - $84.15 $ 93.0123%26,192
David Tepper 2017-03-31 Add 49.63%0.46%$58.31 - $72.42 $ 93.0139%1,174,597
Vanguard Health Care Fund 2017-03-31 New Buy0.11%$58.31 - $72.42 $ 93.0139%668,300
Joel Greenblatt 2017-03-31 Add 12.86%$58.31 - $72.42 $ 93.0139%25,335
David Tepper 2016-12-31 New Buy0.79%$50.68 - $66.8 $ 93.0158%785,000
Joel Greenblatt 2016-12-31 Add 57.66%0.01%$50.68 - $66.8 $ 93.0158%22,449
Joel Greenblatt 2016-09-30 Add 178.38%0.01%$65.3 - $75.39 $ 93.0134%14,239
George Soros 2016-09-30 Sold Out 0.09%$65.3 - $75.39 $ 93.0134%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:WCG, NYSE:MOH, NAS:MGLN, NAS:HIIQ, OTCPK:OPRX, NAS:CNXR, OTCPK:WCUI, OTCPK:HFRN, NYSE:HUM, NAS:ESRX, NYSE:CI, NYSE:ANTM, NYSE:AET, NYSE:CVS, NYSE:UNH » details
Traded in other countries:QEN.Germany,
Headquarter Location:USA
Centene Corp offers healthcare plans to United States government sponsored healthcare programs. The company primarily focuses on uninsured individuals and helps them access care facilities, and social services through government subsidized programs.

Centene offers healthcare plans to United States government sponsored healthcare programs, with a focus on uninsured individuals. It helps members access care, coordinates referrals to health and social services, and provides education and outreach programs to help its members select healthcare services. The firm has a decentralized, regional approach. Centene's managed care segment provides health plan coverage to individuals through government subsidized programs, including Medicare and Medicaid. The specialty services segment consists of specialty companies offering healthcare services and products to state programs, correctional facilities, healthcare organizations, and other commercial organizations. The managed care segment contributes the vast majority of the firm's overall revenue.

Top Ranked Articles about Centene Corp

Louisiana Healthcare Connections Earns Commendable Health Plan Accreditation from NCQA
Coordinated Care Awarded Commendable Accreditation Status From NCQA
Halozyme Up After Cancer Deal, Markets Down Stock soars on deal with Bristol-Myers Squibb
U.S. stock market indexes opened lower on Thursday. Futures for the Dow Jones Industrial Average declined 3 points to 22,109. The Standard & Poor’s 500 index futures lost 2 points to 2,493 and futures for the Nasdaq 100 index declined 7 points to 6,002. The dollar index is down 0.06% at 92.35, while the U.S. 10-year bond yields 2.206% and the German 10-year bond yields 0.415%. Read more...
3 Stocks Advance as Wall Street Moves Back From Record High Inventure Foods, Philip Morris, Aldeyra Therapeutics up in morning trading
U.S. stock market indexes opened lower on Wednesday. Futures for the Dow Jones Industrial Average declined 17 points to 22,073. The Standard & Poor’s 500 index futures lost 4 points to 2,490 and futures for the Nasdaq 100 index declined 12 points to 5,993. The dollar index is up 0.06% at 91.95, while the U.S. 10-year bond yields 2.167% and the German 10-year bond yields 0.401%. Read more...
Centene Corporation To Enter New York Through Transaction With Fidelis Care
Envolve Dental Earns Two URAC Accreditations
Health Net Federal Services Earns URAC Disease Management Accreditation
Centene To Present At Two Upcoming Healthcare Conferences In September
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Centene Corp. (CNC)
Reminder: Centene Corporation's 2017 Third Quarter Financial Results Conference Call

Ratios

vs
industry
vs
history
PE Ratio 20.46
CNC's PE Ratio is ranked higher than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. CNC: 20.46 )
Ranked among companies with meaningful PE Ratio only.
CNC' s PE Ratio Range Over the Past 10 Years
Min: 8.49  Med: 18.69 Max: 2302
Current: 20.46
8.49
2302
Forward PE Ratio 16.81
CNC's Forward PE Ratio is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. CNC: 16.81 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 20.59
CNC's PE Ratio without NRI is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. CNC: 20.59 )
Ranked among companies with meaningful PE Ratio without NRI only.
CNC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.31  Med: 18.7 Max: 70.84
Current: 20.59
8.31
70.84
Price-to-Owner-Earnings 6.02
CNC's Price-to-Owner-Earnings is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. CNC: 6.02 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CNC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.73  Med: 8.24 Max: 122.54
Current: 6.02
3.73
122.54
PB Ratio 2.55
CNC's PB Ratio is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. CNC: 2.55 )
Ranked among companies with meaningful PB Ratio only.
CNC' s PB Ratio Range Over the Past 10 Years
Min: 1.21  Med: 2.17 Max: 4.93
Current: 2.55
1.21
4.93
PS Ratio 0.35
CNC's PS Ratio is ranked higher than
83% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. CNC: 0.35 )
Ranked among companies with meaningful PS Ratio only.
CNC' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.32 Max: 0.57
Current: 0.35
0.19
0.57
Price-to-Free-Cash-Flow 6.40
CNC's Price-to-Free-Cash-Flow is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. CNC: 6.40 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CNC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.63  Med: 7.61 Max: 42.12
Current: 6.4
3.63
42.12
Price-to-Operating-Cash-Flow 5.55
CNC's Price-to-Operating-Cash-Flow is ranked higher than
90% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. CNC: 5.55 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CNC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.89  Med: 5.91 Max: 58.17
Current: 5.55
2.89
58.17
EV-to-EBIT 9.46
CNC's EV-to-EBIT is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. CNC: 9.46 )
Ranked among companies with meaningful EV-to-EBIT only.
CNC' s EV-to-EBIT Range Over the Past 10 Years
Min: -172.2  Med: 9.1 Max: 190.2
Current: 9.46
-172.2
190.2
EV-to-EBITDA 7.87
CNC's EV-to-EBITDA is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. CNC: 7.87 )
Ranked among companies with meaningful EV-to-EBITDA only.
CNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.5  Med: 7.8 Max: 161
Current: 7.87
2.5
161
EV-to-Revenue 0.34
CNC's EV-to-Revenue is ranked higher than
88% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.77 vs. CNC: 0.34 )
Ranked among companies with meaningful EV-to-Revenue only.
CNC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.3 Max: 0.5
Current: 0.34
0.1
0.5
PEG Ratio 0.54
CNC's PEG Ratio is ranked higher than
93% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. CNC: 0.54 )
Ranked among companies with meaningful PEG Ratio only.
CNC' s PEG Ratio Range Over the Past 10 Years
Min: 0.17  Med: 0.78 Max: 213.4
Current: 0.54
0.17
213.4
Shiller PE Ratio 55.59
CNC's Shiller PE Ratio is ranked lower than
92% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. CNC: 55.59 )
Ranked among companies with meaningful Shiller PE Ratio only.
CNC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.13  Med: 44.02 Max: 80.36
Current: 55.59
20.13
80.36
Current Ratio 1.08
CNC's Current Ratio is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CNC: 1.08 )
Ranked among companies with meaningful Current Ratio only.
CNC' s Current Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.04 Max: 1.58
Current: 1.08
0.8
1.58
Quick Ratio 1.08
CNC's Quick Ratio is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CNC: 1.08 )
Ranked among companies with meaningful Quick Ratio only.
CNC' s Quick Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.04 Max: 1.58
Current: 1.08
0.8
1.58
Days Sales Outstanding 30.66
CNC's Days Sales Outstanding is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.28 vs. CNC: 30.66 )
Ranked among companies with meaningful Days Sales Outstanding only.
CNC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.2  Med: 11.25 Max: 30.66
Current: 30.66
9.2
30.66

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 1.90
CNC's 5-Year Yield-on-Cost % is ranked lower than
68% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. CNC: 1.90 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CNC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.9
3-Year Average Share Buyback Ratio -15.80
CNC's 3-Year Average Share Buyback Ratio is ranked lower than
89% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CNC: -15.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CNC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -129.1  Med: -4.75 Max: 0
Current: -15.8
-129.1
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 80.18
CNC's Price-to-Tangible-Book is ranked lower than
99.99% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. CNC: 80.18 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CNC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.09  Med: 3.61 Max: 81.47
Current: 80.18
2.09
81.47
Price-to-Intrinsic-Value-Projected-FCF 0.99
CNC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. CNC: 0.99 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CNC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.37  Med: 0.81 Max: 1.35
Current: 0.99
0.37
1.35
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.89
CNC's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
60% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. CNC: 1.89 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CNC' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 1.6  Med: 2.18 Max: 5.64
Current: 1.89
1.6
5.64
Price-to-Median-PS-Value 1.12
CNC's Price-to-Median-PS-Value is ranked higher than
55% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CNC: 1.12 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CNC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.68  Med: 1.12 Max: 8.68
Current: 1.12
0.68
8.68
Price-to-Peter-Lynch-Fair-Value 0.81
CNC's Price-to-Peter-Lynch-Fair-Value is ranked higher than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CNC: 0.81 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CNC' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.2  Med: 0.72 Max: 38.68
Current: 0.81
0.2
38.68
Price-to-Graham-Number 8.49
CNC's Price-to-Graham-Number is ranked lower than
99.99% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. CNC: 8.49 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CNC' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.01  Med: 1.72 Max: 8.63
Current: 8.49
1.01
8.63
Earnings Yield (Greenblatt) % 10.56
CNC's Earnings Yield (Greenblatt) % is ranked higher than
84% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.85 vs. CNC: 10.56 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CNC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1.8  Med: 10.5 Max: 32.1
Current: 10.56
-1.8
32.1
Forward Rate of Return (Yacktman) % 56.84
CNC's Forward Rate of Return (Yacktman) % is ranked higher than
93% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. CNC: 56.84 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CNC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -8  Med: 26.2 Max: 88.1
Current: 56.84
-8
88.1

More Statistics

Revenue (TTM) (Mil) $46,435.00
EPS (TTM) $ 4.62
Beta0.91
Short Percentage of Float2.78%
52-Week Range $50.00 - 98.72
Shares Outstanding (Mil)172.48

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 47,148 50,910 53,951
EPS ($) 4.89 5.48 6.01
EPS without NRI ($) 4.89 5.48 6.01
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for CNC

Headlines

Articles On GuruFocus.com
Louisiana Healthcare Connections Earns Commendable Health Plan Accreditation from NCQA Sep 22 2017 
Coordinated Care Awarded Commendable Accreditation Status From NCQA Sep 19 2017 
Halozyme Up After Cancer Deal, Markets Down Sep 14 2017 
3 Stocks Advance as Wall Street Moves Back From Record Highs Sep 13 2017 
Centene Corporation To Enter New York Through Transaction With Fidelis Care Sep 12 2017 
Envolve Dental Earns Two URAC Accreditations Sep 07 2017 
Health Net Federal Services Earns URAC Disease Management Accreditation Sep 05 2017 
Centene To Present At Two Upcoming Healthcare Conferences In September Aug 29 2017 
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Centene Corp. (CNC Aug 21 2017 
Reminder: Centene Corporation's 2017 Third Quarter Financial Results Conference Call Aug 21 2017 

More From Other Websites
U.S. Senate opposition to Obamacare repeal bill grows Sep 24 2017
McCain Pulls Plug On GOP Health Bill; Insurers, Hospitals Rally Sep 22 2017
Should Value Investors Consider Centene Corporation (CNC) Stock? Sep 22 2017
Louisiana Healthcare Connections Earns Commendable Health Plan Accreditation from NCQA Sep 22 2017
See what the IHS Markit Score report has to say about Centene Corp. Sep 21 2017
Insurance Industry Comes Out Against Graham-Cassidy Trumpcare Bill Sep 20 2017
Envision Healthcare Makes Organizational Changes, Here's Why Sep 20 2017
Alcoa, Cheesecake Factory, Luminex, Ligand Pharmaceuticals and Centene highlighted as Zacks Bull and... Sep 20 2017
Centene: Cramer's Top Takeaways Sep 20 2017
As clock ticks, Republicans try to move ahead on Obamacare repeal Sep 19 2017
Cramer Remix: Why the Sprint & T-Mobile tie-up might be a done deal Sep 19 2017
Healthcare Reform: Who Suffers? Sep 19 2017
Wall Street Is Taking The Latest ObamaCare Repeal Push Seriously Sep 19 2017
3 Healthcare Stocks to Buy on Renewed Obamacare Repeal Talks Sep 19 2017
Investor expectations for Q3 earnings might be too high: NYSE trader Sep 19 2017
Coordinated Care Awarded Commendable Accreditation Status From NCQA Sep 19 2017
5 Top-Performing Stocks Driving S&P 500 ETF Higher Sep 18 2017
Fidelis Care Buy Could Make Centene Less Likely Takeout Candidate Sep 17 2017
Take Two: Inside Bill Cassidy's Plan To Replace Obamacare Sep 17 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}